Multicenter retrospective evaluation of treatment for high-risk acute promyelocytic leukemia: Real-world outcomes from the HERO consortium Research Letter

  

Authors:	Benitez, L. L.; Marx, K. R.; Rausch, C. R.; Buhlinger, K. M.; Clark, S. M.; Reid, J. H.; Lo, M.; Gatwood, K. S.; Profitt, S.; Shah, R.; Ciervo, J.; Baron, J.; Marini, B. L.; Perissinotti, A. J.; Soule, A.; Waldron, M.; Muluneh, B.
Title:	Multicenter retrospective evaluation of treatment for high-risk acute promyelocytic leukemia: Real-world outcomes from the HERO consortium
Keywords:	adolescent; adult; treatment outcome; aged; middle aged; survival rate; retrospective studies; gene mutation; clinical trial; mortality; methotrexate; outcome assessment; follow up; antineoplastic agent; letter; cytoreductive surgery; antineoplastic combined chemotherapy protocols; incidence; cytogenetics; retrospective study; risk factor; high risk patient; pneumonia; arsenic trioxide; leukemia, promyelocytic, acute; intensive care unit; multicenter study; prophylaxis; urinary tract infection; promyelocytic leukemia; colitis; bacteremia; idarubicin; drug therapy; heart left ventricle ejection fraction; retinoic acid; gemtuzumab ozogamicin; mercaptopurine; hispanic; liver venoocclusive disease; clinical outcome; tretinoin; arsenic; atra; humans; human; male; female; differentiation syndrome; absolute neutrophil count; high risk apl
Journal Title:	American Journal of Hematology
Volume:	100
Issue:	6
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2025-06-01
Start Page:	1094
End Page:	1097
Language:	English
DOI:	10.1002/ajh.27667
PUBMED:	40135741
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105001586309&doi=10.1002%2fajh.27667&partnerID=40&md5=9dfccf61571d929fd7f0c46d93d681d6
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/225607